UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043092
Receipt number R000049187
Scientific Title Evaluation study for intake of a supplement on improvement in blood glucose and metabolic syndrome
Date of disclosure of the study information 2021/01/24
Last modified on 2021/01/22 19:47:32

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation study for intake of a supplement on improvement in blood glucose and metabolic syndrome

Acronym

Evaluation study for intake of a supplement on improvement in metabolic syndrome

Scientific Title

Evaluation study for intake of a supplement on improvement in blood glucose and metabolic syndrome

Scientific Title:Acronym

Evaluation study for intake of a supplement on improvement in metabolic syndrome

Region

Japan


Condition

Condition

Healthy adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate improvement in blood glucose and metabolic syndrome by taking the supplement

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

blood glucose (0-4-8w)

Key secondary outcomes

blood triglyceride
serum LDL-choresterol
BAP
d-ROM
body composition (body weight, body mass index, body fat percentage)
total fat area, Visceral fat area,subcutaneous fat area
height
(0-4-8w)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Intake the supplement for 8 weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

59 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Japanese males and females aged 20 to 59 years old
2) Subjects who satisfy one or more of the following criteria
- 100 to 125mg/dL of blood glucose
- 23 to 30 kg/m2 of BMI
- 120 to 199 mg/dL of blood triglyceride
- 120 to 159 mg/dL of serum LDL-choresterol
3) Subjects who can take 30mL/observation of blood collection
4) Subjects who can fast from 12 hours before the observations
5) Subjects who can agree to go to the test institute to take CT scan
6) Subjects who can take CT scan 2 time during the test period

Key exclusion criteria

1) Subjects with histories of severe liver disorder, renal disorder or heart disease
2) Subjects who participate in other clinical trials
3) Subjects who are currently attending the hospital, taking medical treatments or having dose of medicines
4) Subjects who are pregnant, breast-feeding or have possibility (hope) of pregnancy
5) Subjects who can be allergic to ingredients of the test product
6)Subjects who are taking foods or supplements that can affect the test result
7) Subjects who are taking medicines that can affect the test result

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Koikeda

Organization

Shiba Palace Clinic

Division name

Chair

Zip code

105-0013

Address

DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN

TEL

03-5408-1590

Email

jimukyoku@mail.souken-r.com


Public contact

Name of contact person

1st name Azusa
Middle name
Last name Nishi

Organization

SOUKEN Co., Ltd

Division name

Management Division

Zip code

105-0013

Address

DaiwaA Hamamatsucho Bldg. 3F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN

TEL

03-5408-1555

Homepage URL


Email

a_kouno@mail.souken-r.com


Sponsor or person

Institute

Shiba Palace Clinic



Institute

Department

Personal name



Funding Source

Organization

EZAKI GLICO CO.,LTD.



Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shiba Palace Clinic Ethics Review Committee

Address

DaiwaA Hamamatsucho Bldg. 6F, 1-9-10, Hamamatsucho, Minato-ku, Tokyo, 105-0013, JAPAN

Tel

03-5408-1599

Email

shiba_palace@s-palace-clinic.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 01 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

40

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2020 Year 12 Month 03 Day

Date of IRB

2020 Year 12 Month 10 Day

Anticipated trial start date

2021 Year 01 Month 25 Day

Last follow-up date

2021 Year 06 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 01 Month 22 Day

Last modified on

2021 Year 01 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049187


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name